Premium
Second primary tumors in head and neck cancer patients: The importance of a “tailored” surveillance
Author(s) -
Bertolini Federica,
Trudu Lucia,
Banchelli Federico,
Schipilliti Francesca,
Napolitano Martina,
Alberici Maria Paola,
Depenni Roberta,
D’Angelo Elisa,
Mattioli Francesco,
Rubino Laura,
Presutti Livio
Publication year - 2021
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.13681
Subject(s) - medicine , larynx , head and neck cancer , cancer , primary tumor , incidence (geometry) , lung cancer , population , head and neck squamous cell carcinoma , carcinoma , surgery , oncology , radiology , metastasis , physics , environmental health , optics
Objective Head and neck cancer survivors have increased risk of developing second primary tumors compared to overall population. Because second primary represents a major cause of morbidity and mortality in this population, early detection is fundamental. Materials and Methods In this 10‐year single‐institution study, we investigated the following: incidence, clinical‐pathological risk factors, and survival of patients with second primary tumor. We included all patients with diagnosis of squamous cell carcinoma of the head and neck seen at the Modena University Hospital from 2008 to 2018. Results Among 1,177 patients included, 222 (18.9%) developed second primary tumor; its survival probability at 5 years was 40.6%. Alcohol consumption ( p = .0055) and index cancer in oropharynx ( p = .0029), supraglottic larynx ( p = .0000), glottic larynx ( p = .0222) were associated with higher risk of second primary. The most common second primary sites were head and neck district and lung (70, 31.5%, and 67, 30.2%, respectively). Head and neck district were more common in oral cavity (18, 43%) and oropharynx index cancer (20, 31%); lung second primary in hypopharynx (4, 40%), supraglottic larynx (17, 43%), and glottic larynx index cancer (23, 35%). Conclusion Head and neck cancer survivors developing a second primary tumor have dismal prognosis. Tailored surveillance is recommended.